Teclistamab Significantly Improves Survival Among Patients with Multiple Myeloma Who Previously Received One To Three Lines of Treatment By Ogkologos - June 16, 2026 26 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the MajesTEC-9 study Source RELATED ARTICLESMORE FROM AUTHOR New Targeted Therapy Shows Promising Early Results in Advanced Pancreatic Cancer FDA Approves Pivekimab Sunirine-pvzy for Blastic Plasmacytoid Dendritic Cell Neoplasm, an Ultra-Rare Haematologic Malignancy Ivonescimab Plus Chemotherapy Improves OS Compared with Tislelizumab Plus Chemotherapy in Previously Untreated Patients with Advanced Squamous NSCLC MOST POPULAR How People With Cancer Can Make the Most of Televisits December 4, 2020 2022 ASCO Annual Meeting Research Round Up: New Research in Head... August 25, 2022 EMA Recommends Granting a Marketing Authorisation for Acalabrutinib July 30, 2020 One in Five of Older Patients with EBC Treated in a... December 13, 2022 Load more HOT NEWS Greater OS Benefit Among Patients with Advanced Cancer Treated with Matched... Coronavírus e COVID-19: o que as pessoas com câncer precisam saber “After a fire and a pandemic, it felt amazing to finish... Discovering the BRCA2 gene – 25 years on
